Saluda Medical Pty Limited, a company that deals with the development of closed-loop spinal cord stimulation intended to treat chronic pain, announced on Friday that it has named Jim Schuermann as its new president and chief executive officer.
Mr Schuermann has over 25 years of healthcare and medical device leadership experience. He has held the position of chief business officer at Avedro. He has also served as vice president and general manager of Medtronic's Mechanical Circulatory Support, senior vice president of Sales and Marketing at HeartWare and held various roles at Boston Scientific. He commenced his medical device career at Sherwood-Davis & Geck.
Schuermann has an MBA degree from Golden Gate University and a BS from the Kelley School of Business at Indiana University.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer